Electroconvulsive seizure-induced VEGF is correlated with neuroprotective effects against cerebral infarction: Involvement of the phosphatidylinositol-3 kinase/Akt pathway

Experimental Neurology

Volumn 225, Issue 2, 2010, Pages 377-383

  Fujiki, Minoru ^a   Abe, Eiji ^a   Nagai, Yasuyuki ^a   Shiqi, Kong ^a   Kubo, Takeshi ^a   Ishii, Keisuke ^a   Abe, Tatsuya ^a   Kobayashi, Hidenori ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Cerebral ischemia; Electrical convulsive stimulation; Neuroprotection; PI3K Akt pathway; Vascular endothelial growth factor (VEGF)

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; ELECTROCONVULSIVE THERAPY; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME INDUCTION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; UPREGULATION; ANALYSIS OF VARIANCE; ANIMAL; BRAIN; BRAIN CIRCULATION; ELECTRIC SHOCK; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SEIZURE; SIGNAL TRANSDUCTION; TIME; WESTERN BLOTTING; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; BRAIN; CEREBRAL INFARCTION; CEREBROVASCULAR CIRCULATION; ELECTROSHOCK; MALE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; SEIZURES; SIGNAL TRANSDUCTION; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77956446270     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2010.07.010     Document Type: Article

References (27)

1. Altar C.A., Laeng P., Jurata L.W., Brockman J.A., Lemire A., Bullard J., et al. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J. Neurosci. 2004, 24:2667-2677.
2. Barone F.C., White R.F., Spera P.A., Ellison J., Currie R.W., Wang X., et al. Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke 1998, 29:1937-1950.
3. Bijur G.N., Jope R.S. Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J. Neurochem. 2003, 87:1427-1435.
4. Cardone M.H., Roy N., Stennicke H.R., Salvesen G.S., Franke T.F., Stanbridge E., et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998, 282:1318-1321.
5. Currie R.W., Ellison J.A., White R.F., Feuerstein G.Z., Wang X., Barone F.C. Benign focal ischemic preconditioning induces neuronal Hsp70 and prolonged astrogliosis with expression of Hsp27. Brain Res. 2000, 863:169-181.
6. Du K., Montminy M. CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem. 1998, 273:32377-32379.
7. Duman R.S., Malberg J., Thome J. Neural plasticity to stress and antidepressant treatment. Biol. Psychiatry 1999, 46:1181-1191.
8. Fujiki M., Hikawa T., Abe T., Uchida S., Morishige M., Sugita K., et al. Role of protein kinase C in neuroprotective effect of geranylgeranylacetone, a noninvasive inducing agent of heat shock protein, on delayed neuronal death caused by transient ischemia in rats. J. Neurotrauma 2006, 23:1164-1178.
9. Garcia J.H., Wagner S., Liu K.F., Hu X.J. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 1995, 26:627-634. discussion p. 635.
10. Gross G.J. Pharmacological preconditioning: potential new treatment modalities for the ischemic myocardium. Vascul. Pharmacol. 2005, 42:199.
11. Kilic E., Kilic U., Wang Y., Bassetti C.L., Marti H.H., Hermann D.M. The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J. 2006, 20:1185-1187.
12. Kirino T., Nakagomi T., Kanemitsu H., Tamura A. Ischemic tolerance. Adv. Neurol. 1996, 71:505-511.
13. Li L., Qu Y., Mao M., Xiong Y., Mu D. The involvement of phosphoinositid 3-kinase/Akt pathway in the activation of hypoxia-inducible factor-1alpha in the developing rat brain after hypoxia-ischemia. Brain Res. 2008, 1197:152-158.
14. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
15. Majima M., Hayashi I., Muramatsu M., Katada J., Yamashina S., Katori M. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br. J. Pharmacol. 2000, 130:641-649.
16. Nakae J., Barr V., Accili D. Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR. EMBO J. 2000, 19:989-996.
17. Newton S.S., Collier E.F., Hunsberger J., Adams D., Terwilliger R., Selvanayagam E., et al. Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J. Neurosci. 2003, 23:10841-10851.
18. Nicoletti J.N., Shah S.K., McCloskey D.P., Goodman J.H., Elkady A., Atassi H., et al. Vascular endothelial growth factor is up-regulated after status epilepticus and protects against seizure-induced neuronal loss in hippocampus. Neuroscience 2008, 151:232-241.
19. Sairanen M., Lucas G., Ernfors P., Castrén M., Castrén E. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J. Neurosci. 2005, 25:1089-1094.
20. Steward O., Kelley M.S., Schauwecker P.E. Signals that regulate astroglial gene expression: induction of GFAP mRNA following seizures or injury is blocked by protein synthesis inhibitors. Exp. Neurol. 1997, 148:100-109.
21. Sun F.Y., Guo X. Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor. J. Neurosci. Res. 2005, 79:180-184.
22. Tao X., Finkbeiner S., Arnold D.B., Shaywitz A.J., Greenberg M.E. Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 1998, 20:709-726.
23. Warner-Schmidt J.L., Duman R.S. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc. Natl Acad. Sci. USA 2007, 104:4647-4652.
24. Wu M., Komori N., Qin C., Farber J.P., Linderoth B., Foreman R.D. Extracellular signal-regulated kinase (ERK) and protein kinase B (AKT) pathways involved in spinal cord stimulation (SCS)-induced vasodilation. Brain Res. 2008, 1207:73-83.
25. Yamanaka K., Takahashi N., Ooie T., Kaneda K., Yoshimatsu H., Saikawa T. Role of protein kinase C in geranylgeranylacetone-induced expression of heat-shock protein 72 and cardioprotection in the rat heart. J. Mol. Cell. Cardiol. 2003, 35:785-794.
26. Yano S., Morioka M., Fukunaga K., Kawano T., Hara T., Kai Y., et al. Activation of Akt/protein kinase B contributes to induction of ischemic tolerance in the CA1 subfield of gerbil hippocampus. J. Cereb. Blood Flow Metab. 2001, 21:351-360.
27. Yin W., Signore A.P., Iwai M., Cao G., Gao Y., Johnnides M.J., et al. Preconditioning suppresses inflammation in neonatal hypoxic ischemia via Akt activation. Stroke 2007, 38:1017-1024.